A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"blurhash": "toot:blurhash",
"focalPoint": {
"@container": "@list",
"@id": "toot:focalPoint"
},
"Hashtag": "as:Hashtag"
}
],
"id": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2025-03-18T10:26:26Z",
"url": "https://mastodon.social/@ottobusenbach/114182952468303150",
"attributedTo": "https://mastodon.social/users/ottobusenbach",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://mastodon.social/users/ottobusenbach/followers"
],
"sensitive": false,
"atomUri": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150",
"inReplyToAtomUri": null,
"conversation": "tag:mastodon.social,2025-03-18:objectId=948865965:objectType=Conversation",
"content": "<p>Cambridge-based Maxion Therapeutics raises €68.9 million in Series A funding led by General Catalyst to advance its KnotBody pipeline targeting ion channel and GPCR-driven diseases.Maxion Therapeutics, a Cambridge-based biotech firm, has raised €68.9 million in a Series A funding round led by General Catalyst. <a href=\"https://mastodon.social/tags/biotech\" class=\"mention hashtag\" rel=\"tag\">#<span>biotech</span></a> <a href=\"https://mastodon.social/tags/drugdevelopment\" class=\"mention hashtag\" rel=\"tag\">#<span>drugdevelopment</span></a> <a href=\"https://mastodon.social/tags/funding\" class=\"mention hashtag\" rel=\"tag\">#<span>funding</span></a> <a href=\"https://mastodon.social/tags/GPCR\" class=\"mention hashtag\" rel=\"tag\">#<span>GPCR</span></a> <a href=\"https://mastodon.social/tags/ionchannels\" class=\"mention hashtag\" rel=\"tag\">#<span>ionchannels</span></a> </p><p><a href=\"https://redrobot.online/2025/03/maxion-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/\" target=\"_blank\" rel=\"nofollow noopener\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">redrobot.online/2025/03/maxion</span><span class=\"invisible\">-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/</span></a></p>",
"contentMap": {
"en": "<p>Cambridge-based Maxion Therapeutics raises €68.9 million in Series A funding led by General Catalyst to advance its KnotBody pipeline targeting ion channel and GPCR-driven diseases.Maxion Therapeutics, a Cambridge-based biotech firm, has raised €68.9 million in a Series A funding round led by General Catalyst. <a href=\"https://mastodon.social/tags/biotech\" class=\"mention hashtag\" rel=\"tag\">#<span>biotech</span></a> <a href=\"https://mastodon.social/tags/drugdevelopment\" class=\"mention hashtag\" rel=\"tag\">#<span>drugdevelopment</span></a> <a href=\"https://mastodon.social/tags/funding\" class=\"mention hashtag\" rel=\"tag\">#<span>funding</span></a> <a href=\"https://mastodon.social/tags/GPCR\" class=\"mention hashtag\" rel=\"tag\">#<span>GPCR</span></a> <a href=\"https://mastodon.social/tags/ionchannels\" class=\"mention hashtag\" rel=\"tag\">#<span>ionchannels</span></a> </p><p><a href=\"https://redrobot.online/2025/03/maxion-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/\" target=\"_blank\" rel=\"nofollow noopener\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">redrobot.online/2025/03/maxion</span><span class=\"invisible\">-therapeutics-secures-e68-million-in-series-a-funding-for-antibody-based-drug-development/</span></a></p>"
},
"attachment": [
{
"type": "Document",
"mediaType": "image/jpeg",
"url": "https://files.mastodon.social/media_attachments/files/114/182/952/447/523/354/original/6f010d836d28adf8.jpeg",
"name": null,
"blurhash": "UuJbs;o#x]M|00t6xaof?GaeRkjto~j@xtM{",
"width": 1024,
"height": 1024
}
],
"tag": [
{
"type": "Hashtag",
"href": "https://mastodon.social/tags/biotech",
"name": "#biotech"
},
{
"type": "Hashtag",
"href": "https://mastodon.social/tags/drugdevelopment",
"name": "#drugdevelopment"
},
{
"type": "Hashtag",
"href": "https://mastodon.social/tags/funding",
"name": "#funding"
},
{
"type": "Hashtag",
"href": "https://mastodon.social/tags/gpcr",
"name": "#gpcr"
},
{
"type": "Hashtag",
"href": "https://mastodon.social/tags/ionchannels",
"name": "#ionchannels"
}
],
"replies": {
"id": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150/replies?only_other_accounts=true&page=true",
"partOf": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150/replies",
"items": []
}
},
"likes": {
"id": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150/likes",
"type": "Collection",
"totalItems": 0
},
"shares": {
"id": "https://mastodon.social/users/ottobusenbach/statuses/114182952468303150/shares",
"type": "Collection",
"totalItems": 0
}
}